Advertisement
Advertisement
U.S. Markets open in 3 hrs 39 mins
Advertisement
Advertisement
Advertisement
Advertisement

Ampio Pharmaceuticals, Inc. (AMPE)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.2182+0.0048 (+2.25%)
At close: 04:00PM EDT
0.2182 0.00 (0.00%)
After hours: 06:34PM EDT
Advertisement
Sign in to post a message.
  • F
    Frank
    Told you. The last OAK trial used previous flawed results to make their claims of a relevant p value. Where are you Nurse Chrissy?
  • t
    terry
    lost money on this 10 years ago - nothing changed except they issue more shares biggest fraud I've ever seen
  • B
    Bruce
    Is the plan here to not release what they said so only those that got up early enough with little warning are the only ones who know? When are they going to release what the FDA said?
  • B
    Bruce
    Wow! Talk about a late notice! OMG! They announce the conference call late yesterday and then hold it early today? Must not be good news.
  • p
    pete
    AMPE CC - we are completely hosed. Between 10 and 20 million needed for another PH III trial, which in all
    likelyhood will be needed,

    I don't see how they survive without severely dilutive vampire financing,
  • Y
    Y2K'22
    How is this scam allowed to go on? Why are shares even allowed to trade still?
  • p
    pete
    Like this didn't leak weeks ago!!! Insiders always know before retail traders.

    Please!!!!!! Now we can clearly see why it has precipitously dropped over the past few weeks.
  • p
    pete
    Are we looking at another R/S???? Sure seems like something bad is going to happen and the news leaked sometime in early January. The downward spiral is accelerating since then.
  • j
    jd.fierre
    Ballooning expenses and cash burn rate, even with accounts payable significantly higher, reduce the sparkle from the cash number. AP-017 is a dud and the other Covid trials are on track to have data analysis completed by the end of the second quarter, but hey if you massage the numbers enough times on the knee trial, there's still a snow ball's chance. And preliminary lists for Russell Reconstitution begin on June 3.
  • p
    pete
    Where is the $$$ for yet another Ph III trial going to come from? 18 more months????

    Mike Martino Chief Executive Officer and Chairman of Ampio. "However, I want to be clear. At this point, I believe the best path forward for Ampio and Ampion is likely conducting a new Phase 3 trial. This management team has learned a great deal from conducting and analyzing the prior trials, including AP-013, and believe we are positioned to design and execute a trial that can lead to BLA approval."
  • K
    K
    $2.20 is my break even...
  • L
    Len
    added 200 shares to average down… will be glad if tis go .60 😅
  • H
    Honest Dude
    Whoever just covered a long held short made some cash here for sure.... wonder who that was, prolly Macaliar.
  • T
    Twobux
    Did anyone see Tony Robbins on Tucker Carlson and was he talking about Ampion?
  • Y
    Y2K'22
    SCAMMEDPIO - IF THEY CAN RUN JUST JUST ONE MORE THE PRODUCERS SCAM! A PRODUCT DESIGNED TO FAIL BEFORE FDA TRIALS FOR 10 YEARS!
  • Y
    Y2K'22
    Springtime for Hitler...
  • r
    renato
    bought some at .56
    i'm late comer here.
  • a
    allen
    i will never understand why the FDA made them do a second phase 3 with over 100 cohorts Unheard of in the industry for a pain drug like ampion for the knee. I think it’s clear these company’s are more designed as money making s hemes and less about drug development
  • J
    John J
    Time to terminate this entire Mgmt team, including the BOD.
  • P
    Patrick
    Why the jump?
Advertisement
Advertisement